Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Zenotech Laboratories Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Devendra Chandrakant Kenkre

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	3.8yrs
CEO sahipliği	n/a
Yönetim ortalama görev süresi	8.6yrs
Yönetim Kurulu ortalama görev süresi	9yrs

Son yönetim güncellemeleri

Recent updates

CEO

Devendra Chandrakant Kenkre

3.8yrs

Görev süresi

Mr. Devendra Chandrakant Shenvi Kenkre serves as Chief Executive Officer at Zenotech Laboratories Limited since January 23, 2021. He has experience in the pharma 1ndustry. He was earlier associated with E...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Devendra Chandrakant Kenkre	Chief Executive Officer	3.8yrs	Veri yok	Veri yok
Kachappilly Poly	Chief Financial Officer	9.4yrs	₹993.00k	Veri yok
K. Reddy	Head of HR & Admin	no data	Veri yok	Veri yok
Abdul Mohammad	Company Secretary & Compliance Officer	8.6yrs	₹67.98k	Veri yok
Ramesh Kumar	Head of Engineering	no data	Veri yok	Veri yok
Sanjay Agarwal	Head of Production	no data	Veri yok	Veri yok
Chandrasekhar Dasu	Head of Quality	no data	Veri yok	Veri yok

8.6yrs

Ortalama Görev Süresi

Deneyimli Yönetim: 532039 'un yönetim ekibi deneyimli ve deneyimlidir ( 8.6 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Kavita Shah	Independent Non-Executive Director	9.5yrs	₹75.00k	Veri yok
Jignesh Goradia	Non Independent Non-Executive Director	9.3yrs	₹75.00k	Veri yok
Azadar Hussain Asghar Khan	Non-Independent Non-Executive Chairman	9.2yrs	Veri yok	Veri yok
Chintan Shah	Independent Non-Executive Director	8.8yrs	₹75.00k	Veri yok
Jagruti Sheth	Independent Non-Executive Director	4.7yrs	₹75.00k	Veri yok
Rakeshchandra Sinha	Non-Independent Non Executive Director	4.7yrs	Veri yok	Veri yok

9.0yrs

Ortalama Görev Süresi

57yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: 532039 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 9 yıldır).

Zenotech Laboratories Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Zenotech Laboratories Limited, Annual General Meeting, Sep 27, 2024

Zenotech Laboratories Limited Announces Resignation of Devendra Chandrakant Shenvi Kenkre as Chief Executive Officer, Effective August 12, 2024

Insufficient new directors

Zenotech Laboratories Limited, Annual General Meeting, Sep 29, 2023

Insufficient new directors

Zenotech Laboratories Limited, Annual General Meeting, Sep 24, 2022

Recent updates

New minor risk - Share price stability

Investor sentiment improves as stock rises 24%

Zenotech Laboratories Limited, Annual General Meeting, Sep 27, 2024

First quarter 2025 earnings released: EPS: ₹0.21 (vs ₹0.35 in 1Q 2024)

Zenotech Laboratories Limited to Report Q1, 2025 Results on Jul 26, 2024

Zenotech Laboratories Limited Announces Resignation of Devendra Chandrakant Shenvi Kenkre as Chief Executive Officer, Effective August 12, 2024

Full year 2024 earnings released: EPS: ₹1.36 (vs ₹1.90 in FY 2023)

Zenotech Laboratories Limited to Report Q4, 2024 Results on May 01, 2024

Insufficient new directors

Investor sentiment improves as stock rises 17%

Third quarter 2024 earnings released: EPS: ₹0.55 (vs ₹0.23 in 3Q 2023)

Zenotech Laboratories Limited to Report Q3, 2024 Results on Jan 29, 2024

Investor sentiment improves as stock rises 15%

Second quarter 2024 earnings released: EPS: ₹0.46 (vs ₹0.45 in 2Q 2023)

Investor sentiment deteriorates as stock falls 17%

Zenotech Laboratories Limited to Report Q2, 2024 Results on Oct 30, 2023

New minor risk - Share price stability

Investor sentiment improves as stock rises 20%

Zenotech Laboratories Limited, Annual General Meeting, Sep 29, 2023

Zenotech Laboratories Limited to Report Q1, 2024 Results on Aug 01, 2023

Full year 2023 earnings released: EPS: ₹1.90 (vs ₹3.63 in FY 2022)

Insufficient new directors

Zenotech Laboratories Limited to Report Q3, 2023 Results on Jan 27, 2023

Investor sentiment improved over the past week

Zenotech Laboratories Limited to Report Q2, 2023 Results on Oct 28, 2022

Zenotech Laboratories Limited, Annual General Meeting, Sep 24, 2022

First quarter 2023 earnings released: EPS: ₹0.62 (vs ₹0.57 in 1Q 2022)

Zenotech Laboratories Limited to Report Q1, 2023 Results on Jul 22, 2022

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Full year 2022 earnings released: EPS: ₹3.63 (vs ₹0.20 loss in FY 2021)

Zenotech Laboratories Limited to Report Q4, 2022 Results on Apr 29, 2022

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Second quarter 2022 earnings released: EPS ₹0.16 (vs ₹0.34 loss in 2Q 2021)

First quarter 2022 earnings released: EPS ₹0.57 (vs ₹0.20 loss in 1Q 2021)

Full year 2021 earnings released: ₹0.20 loss per share (vs ₹1.77 profit in FY 2020)

New 90-day high: ₹39.50

Zenotech Laboratories Limited Appoints Devendra Chandrakant S. Kenkre as Chief Executive Officer

Zenotech Laboratories Limited to Report Q3, 2021 Results on Jan 23, 2021

Investor sentiment improved over the past week

Market bids up stock over the past week

Second quarter 2021 earnings released: ₹0.34 loss per share

New 90-day high: ₹36.55

New 90-day high: ₹29.95

New 90-day high - ₹25.75

CEO

Görev süresi

Liderlik Ekibi

Ortalama Görev Süresi

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi

Ortalama Yaş